beta2-microglobulin is a signaling and growth-promoting factor for human prostate cancer bone metastasis
about
iTRAQ identification of candidate serum biomarkers associated with metastatic progression of human prostate cancerBeta2-microglobulin signaling blockade inhibited androgen receptor axis and caused apoptosis in human prostate cancer cellsβ2-Microglobulin-mediated signaling as a target for cancer therapyDecipher β2-microglobulin: gain- or loss-of-function (a mini-review)RANK-mediated signaling network and cancer metastasis.Androgen receptor survival signaling is blocked by anti-beta2-microglobulin monoclonal antibody via a MAPK/lipogenic pathway in human prostate cancer cells.Killing tumor cells through their surface beta(2)-microglobulin or major histocompatibility complex class I molecules.Novel immunotherapiesCharacterization of β2-microglobulin expression in different types of breast cancer.Anti-β₂M monoclonal antibodies kill myeloma cells via cell- and complement-mediated cytotoxicity.Inhibition of β2-microglobulin/hemochromatosis enhances radiation sensitivity by induction of iron overload in prostate cancer cellsMicroRNA-185 and 342 inhibit tumorigenicity and induce apoptosis through blockade of the SREBP metabolic pathway in prostate cancer cellsTargeting cell surface β2 -microglobulin by pentameric IgM antibodiesβ2-microglobulin induces epithelial to mesenchymal transition and confers cancer lethality and bone metastasis in human cancer cells.Anti-β₂-microglobulin monoclonal antibodies overcome bortezomib resistance in multiple myeloma by inhibiting autophagy.Microsatellite instability and Beta2-Microglobulin mutations as prognostic markers in colon cancer: results of the FOGT-4 trialFuture perspectives of prostate cancer therapy.Upregulation of β2-microglobulin expression in progressive human oral squamous cell carcinomaThe Implication and Significance of Beta 2 Microglobulin: A Conservative Multifunctional Regulator.Circulating Beta-2 Microglobulin and Risk of Cancer: The Atherosclerosis Risk in Communities Study (ARIC)Perlecan/HSPG2 and matrilysin/MMP-7 as indices of tissue invasion: tissue localization and circulating perlecan fragments in a cohort of 288 radical prostatectomy patientsOverexpression of beta2-microglobulin is associated with poor survival in patients with oral cavity squamous cell carcinoma and contributes to oral cancer cell migration and invasion.Monoclonal antibodies directed against chicken β2-microglobulin developed with a synthesized peptide.Cadherin-11 promotes the metastasis of prostate cancer cells to bone.alpha-CaMKII controls the growth of human osteosarcoma by regulating cell cycle progression.Tumor-stroma co-evolution in prostate cancer progression and metastasis.RANK- and c-Met-mediated signal network promotes prostate cancer metastatic colonization.Implication of the β2-microglobulin gene in the generation of tumor escape phenotypes.Towards a vaccine to prevent cancer in Lynch syndrome patients.miR-154* and miR-379 in the DLK1-DIO3 microRNA mega-cluster regulate epithelial to mesenchymal transition and bone metastasis of prostate cancerRadiation modulation of microRNA in prostate cancer cell lines.MiRNA 34a: a therapeutic target for castration-resistant prostate cancer.Induction of integrin α2 in a highly bone metastatic human prostate cancer cell line: roles of RANKL and AR under three-dimensional suspension culture.Adenovirus expressing β2-microglobulin recovers HLA class I expression and antitumor immunity by increasing T-cell recognition.Expression kinetics of chicken β2-microglobulin and Class I MHC in vitro and in vivo during Marek's disease viral infections.Human positive coactivator 4 is a potential novel therapeutic target in non-small cell lung cancer.Critical and distinct roles of p16 and telomerase in regulating the proliferative life span of normal human prostate epithelial progenitor cells.Beta2-microglobulin as a potential factor for the expansion of mesenchymal stem cells.Presence of bone marrow micrometastasis is associated with different recurrence risk within molecular subtypes of breast cancerEpithelial to mesenchymal transition (EMT) in human prostate cancer: lessons learned from ARCaP model
P2860
Q21134794-214D64C1-16EC-43FF-9BCF-9EB88EDB8720Q24631263-F1FCFC0C-B303-4FD6-BF5C-FF29B14362A8Q26853735-FAC2BF77-3D72-4E05-829A-DCC72DA6CDA8Q27023695-A750E499-D49F-4CB2-A8CB-C84A9C2F1863Q30371052-1024BC0F-CA46-46B1-8B78-0DF70FBFD80DQ33706967-2DC0F2E1-DF17-4B62-BAC4-9F6949678F8BQ33759555-3E23EC26-DBBB-4C86-BC9B-B8F7B378580DQ33822677-EFF00392-ACEF-4834-85D3-DD21652BF5BCQ34340124-EC9F8756-EC59-42E3-877F-167D1B854124Q34502870-18324CB4-F9EE-4F62-AD0B-E62E692AA9E4Q34848208-A4B6C6AB-D6F7-4D8D-BBD7-D02291465E6EQ34948292-222F163B-60AD-4BA9-8285-7850BA853D97Q35036633-D9833AA7-817D-4082-B831-A90679AAA6FEQ35237763-517BEB58-27B6-4F91-9EC4-E0C505E2B766Q35832168-6A004FC7-6230-4E07-AC6B-3F87B704B7A1Q35832345-1C32ACE7-B349-4903-B9C2-F47117856CF4Q36076453-8D3C98E3-19B5-4D4C-BE10-F7187401FE0EQ36642602-6FD4DE4F-5204-4BF3-A613-DFB9C82BA352Q36709380-924858D8-9A24-4987-BEDA-4FBEA0F7F4B8Q36918121-F13AA0EF-67E8-45C2-A752-994304CD2EEDQ36962989-367F0A6D-56A0-480C-A3CC-3C7DA972CCFFQ36965088-5031D7BD-E58B-4353-AD4B-202EC83578D3Q37069171-F0D1DCBB-A25A-42F8-A014-B006536C4750Q37100123-08D4FD3A-47EC-488A-8AB6-F30EA47346D0Q37319003-124B40D0-029A-47EA-817B-6B9E656402DFQ37641468-632FCB61-3240-4041-8ADA-0A19116E5127Q37648868-2621BFEF-1101-4AEC-A1B3-1D9017E51959Q38029543-DE041CDD-922E-491F-9232-70DC003D52F6Q38113960-7D1AEFAA-19A3-4AC3-98B1-1BB6A2461913Q38447274-2261EC16-0C26-4140-B4E8-58B5DEC8F184Q38583993-149B1E8E-1AC8-4A23-9944-F6CA081E3B62Q38760500-3E549D2A-0113-46BE-97A4-645AB080B99CQ38958606-6AAFA06D-E7CF-4D59-B511-E87662C56005Q38980455-5994F9EB-7D9A-4515-B03D-D0241E7AA066Q39114868-4881332A-43A1-45F6-B261-C5B0E1DD3939Q39291884-7F359D59-F35A-4B76-AAA8-7C2FEFAC9157Q39956460-3181833B-6C15-4856-861C-5DD747646CA6Q39977255-5152982A-EC0C-4FA5-8E2F-682EFC00C28CQ41252044-70F4B84F-5691-48FF-988A-899CAD301E51Q41902936-799F566B-6B15-4ADF-AC89-9287EA82140E
P2860
beta2-microglobulin is a signaling and growth-promoting factor for human prostate cancer bone metastasis
description
2006 nî lūn-bûn
@nan
2006 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
beta2-microglobulin is a signa ...... rostate cancer bone metastasis
@ast
beta2-microglobulin is a signa ...... rostate cancer bone metastasis
@en
beta2-microglobulin is a signa ...... rostate cancer bone metastasis
@nl
type
label
beta2-microglobulin is a signa ...... rostate cancer bone metastasis
@ast
beta2-microglobulin is a signa ...... rostate cancer bone metastasis
@en
beta2-microglobulin is a signa ...... rostate cancer bone metastasis
@nl
prefLabel
beta2-microglobulin is a signa ...... rostate cancer bone metastasis
@ast
beta2-microglobulin is a signa ...... rostate cancer bone metastasis
@en
beta2-microglobulin is a signa ...... rostate cancer bone metastasis
@nl
P2093
P1433
P1476
beta2-microglobulin is a signa ...... rostate cancer bone metastasis
@en
P2093
Chia-Ling Hsieh
Haiyen E Zhau
Leland W K Chung
M Neale Weitzmann
Majd Zayzafoon
Mary C Farach-Carson
Takeo Nomura
Wen-Chin Huang
P304
P356
10.1158/0008-5472.CAN-06-1996
P407
P577
2006-09-15T00:00:00Z